Tasly Establishes Joint Venture With France's Transgene SA
This article was originally published in PharmAsia News
Executive Summary
Tianjin Tasly Group and French company Transgene SA held a signing ceremony on May 18 establishing a joint venture and creating Tasly Chuangshijie (Tianjin) Biotech
Tianjin Tasly Group and French company Transgene SA held a signing ceremony on May 18 establishing a joint venture and creating Tasly Chuangshijie (Tianjin) Biotech. The new company will be dedicated to the development of biologics. A subsidiary of the Mérieux Alliance Group, Transgene SA is a NASDAQ-listed biotech company with successful research in cancer and infectious disease therapiesy. Noting the cutting-edge nature of biopharmaceutical R&D, Tianjin municipal government representative Li Wenxi expressed certainty that the combined strengths of the two companies will result in significant R&D progress in the field. (Click Here For More - Chinese Language) "Sino-French Joint Venture Tasly Shijie (Tianjin) Biotech"- 022net.com (5.18.10) |